Acadia Healthcare (NASDAQ:ACHC) issued its earnings results on Monday. The company reported $0.55 EPS for the quarter, missing analysts’ consensus estimates of $0.64 by ($0.09), Briefing.com reports. Acadia Healthcare had a net margin of 7.52% and a return on equity of 7.93%. The firm had revenue of $760.90 million during the quarter, compared to analyst estimates of $760.46 million. During the same quarter in the previous year, the company posted $0.58 earnings per share. The business’s revenue for the quarter was up 6.2% compared to the same quarter last year. Acadia Healthcare updated its FY 2018 guidance to $2.25-2.27 EPS and its FY18 guidance to $2.25-2.27 EPS.
NASDAQ:ACHC traded down $2.01 during trading hours on Tuesday, reaching $38.57. The company had a trading volume of 4,945,059 shares, compared to its average volume of 3,350,341. Acadia Healthcare has a one year low of $26.92 and a one year high of $45.35. The stock has a market capitalization of $3.95 billion, a price-to-earnings ratio of 16.77, a price-to-earnings-growth ratio of 1.60 and a beta of 0.22. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.24 and a quick ratio of 1.24.
In other news, Director Reeve B. Waud sold 41,865 shares of the stock in a transaction on Thursday, November 1st. The stock was sold at an average price of $45.00, for a total transaction of $1,883,925.00. Following the sale, the director now owns 14,213 shares in the company, valued at $639,585. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 2.50% of the stock is currently owned by corporate insiders.
Several hedge funds have recently made changes to their positions in the company. Bbva Compass Bancshares Inc. grew its holdings in shares of Acadia Healthcare by 29.7% during the third quarter. Bbva Compass Bancshares Inc. now owns 8,222 shares of the company’s stock worth $289,000 after purchasing an additional 1,884 shares during the last quarter. Condor Capital Management grew its holdings in shares of Acadia Healthcare by 9.0% during the third quarter. Condor Capital Management now owns 19,526 shares of the company’s stock worth $687,000 after purchasing an additional 1,611 shares during the last quarter. Arizona State Retirement System grew its holdings in shares of Acadia Healthcare by 10.0% during the third quarter. Arizona State Retirement System now owns 62,679 shares of the company’s stock worth $2,206,000 after purchasing an additional 5,708 shares during the last quarter. Levin Capital Strategies L.P. grew its holdings in shares of Acadia Healthcare by 77.9% during the third quarter. Levin Capital Strategies L.P. now owns 15,960 shares of the company’s stock worth $562,000 after purchasing an additional 6,990 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. grew its holdings in shares of Acadia Healthcare by 10.2% during the third quarter. Oppenheimer Asset Management Inc. now owns 18,111 shares of the company’s stock worth $638,000 after purchasing an additional 1,672 shares during the last quarter.
ACHC has been the topic of a number of analyst reports. Zacks Investment Research upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and set a $48.00 price target on the stock in a research report on Tuesday, July 24th. BidaskClub upgraded Acadia Healthcare from a “hold” rating to a “buy” rating in a research report on Thursday, September 6th. Jefferies Financial Group upped their price target on Acadia Healthcare from $44.00 to $47.00 and gave the company a “buy” rating in a research report on Tuesday, July 31st. Mizuho set a $37.00 price target on Acadia Healthcare and gave the company a “hold” rating in a research report on Tuesday, August 28th. Finally, Craig Hallum cut Acadia Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday, October 17th. They noted that the move was a valuation call. Eight analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Acadia Healthcare currently has an average rating of “Hold” and a consensus price target of $43.11.
ILLEGAL ACTIVITY WARNING: “Acadia Healthcare (ACHC) Releases Earnings Results, Misses Estimates By $0.09 EPS” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The correct version of this story can be accessed at https://www.dispatchtribunal.com/2018/11/06/acadia-healthcare-achc-releases-earnings-results-misses-estimates-by-0-09-eps.html.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.
Featured Article: 52-Week High/Low Prices For Stock Selection
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.